The chart below shows the treatments and participant groups the researchers planned to study. 28 participants in total:
- 14 participants were smokers
- 14 participants were non-smokers
- AZD4635 as capsules by mouth
- Fluvoxamine as tablets by mouth

Part 1:
- 1 dose of AZD4635

Part 2:
- Fluvoxamine every day for 10 days
- 1 dose of AZD4635 with fluvoxamine

4 